AZ and Oracle team up on AI platform for clinical trials
AstraZeneca has launched a project with tech giant Oracle that will try to use AI and real-world data to improve clinical research and patient care.
Newsletters and Deep Dive digital magazine
AstraZeneca has launched a project with tech giant Oracle that will try to use AI and real-world data to improve clinical research and patient care.
A year after signing a first deal with Hansoh worth up to $1.45 billion, Roche has returned for another that could be more than 10 times larger.
Merck KGaA has reached a deal to acquire UK-based Silence Therapeutics in a $1.3bn deal that would give it a late-stage drug for polycythemia vera.
September’s boardroom moves brought seasoned pharma executives, investors, and scientific leaders into new governance and advisory roles across the life sciences sector.
The UK Biobank has teamed up with industry partners to create "the world’s most detailed, large-scale picture of the human immune system."
Editor's Picks
Newsletters and Deep Dive
digital magazine